— Know what they know.
Not Investment Advice

DCTH NASDAQ

Delcath Systems, Inc.
1W: -0.1% 1M: -6.7% 3M: +27.4% YTD: +48.2% 1Y: +44.2% 3Y: +309.7% 5Y: +48.7%
$14.75
+0.24 (+1.65%)
 
Weekly Expected Move ±5.7%
$13 $14 $14 $15 $16
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $511.8M mcap · 32M float · 1.42% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 87% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.9%), Delcath Systems, Inc. would be worth roughly what it owes.
Total debt $2.5M against a stock market value of $511.8M.
Distance to default 12.19 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 49.0%; Altman Z 15.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-04-26
Earliest Filing
2024-04-26
Latest Filing
partner: 2

Counterparties (Filed by DCTH)

2 relationships

Companies named in DCTH's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Synerx Pharma, LLC — partner Counterparty to License, Supply and Contract Manufacturing Agreement 2024-04-26 View
Mylan Teoranta — partner Counterparty to License, Supply and Contract Manufacturing Agreement 2024-04-26 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-14 Bylaws Amendment; Exhibits View
2026-08-06 Earnings Release; Exhibits View
2026-05-14 Officer/Director Change; Shareholder Vote; Exhibits View
2026-05-07 Earnings Release; Exhibits View
2026-03-03 Other Events; Financial Statements and Exhibits View
2026-02-26 Results of Operations and Financial Condition View
2026-01-12 Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta View
2025-11-20 Other Events View
2025-11-04 Results of Operations and Financial Condition View
2025-10-20 Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta View
2025-08-15 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2025-08-06 Results of Operations and Financial Condition View
2025-05-22 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-16 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-05-08 Results of Operations and Financial Condition View
2025-03-21 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2025-03-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-13 Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta View
2024-12-30 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2024-11-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms